Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Neoadjuvant Chemotherapy With Docetaxel, Cisplatin Followed by Maintenance Therapy With the EGFR Inhibitor Erlotinib (Tarceva) in Patients With Stage I, II and III Non-Small Cell Lung Cancer Following Definitive Surgical Resection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00254384
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:23.784034+00:00
Published At
2024-07-05T00:00:00+00:00
Record Updated At
2024-07-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Lung Non-Small Cell Carcinoma", "Stage IA Lung Non-Small Cell Carcinoma AJCC v7", "Stage IB Lung Non-Small Cell Carcinoma AJCC v7", "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7", "Stage IIB Lung Non-Small Cell Carcinoma AJCC v7", "Stage IIIA Lung Non-Small Cell Cancer AJCC v7", "Stage IIIB Lung Non-Small Cell Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-05"
protocolSection.identificationModule.nctId
"NCT00254384"
protocolSection.identificationModule.officialTitle
"Neoadjuvant Chemotherapy With Docetaxel, Cisplatin Followed by Maintenance Therapy With the EGFR Inhibitor Erlotinib (Tarceva) in Patients With Stage I, II and III Non-Small Cell Lung Cancer Following Definitive Surgical Resection"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Recurrent Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IA Lung Non-Small Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IB Lung Non-Small Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.